» Articles » PMID: 1936703

Consequences of Systemic Venous Drainage and Denervation of Heterotopic Pancreatic Transplants for Insulin/C-peptide Profiles in the Basal State and After Oral Glucose

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1991 Aug 1
PMID 1936703
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma glucose, immunoreactive insulin and C-peptide concentrations were compared in nine pancreas-kidney-transplanted patients (systemic venous drainage) and in ten non-diabetic kidney-transplanted patients with similar kidney function. In the basal state, C-peptide (insulin secretion) was similar, but immunoreactive insulin was higher and glucose concentrations were slightly, but significantly lower in pancrease-transplanted patients. After 50 g oral glucose, the plasma glucose and IR-insulin profiles were similar in both groups. The circumvention of first-pass hepatic insulin extraction (decreased endogenous insulin clearance) was compensated for by a significant reduction in insulin secretion (C-peptide; p = 0.036). In conclusion, hyperinsulinaemia in pancreas-transplanted patients with systemic venous drainage is significant only in the basal state. Insulin delivered into the portal and peripheral circulation, when leading to similar insulin profiles, maintains comparable degrees of glucose tolerance.

Citing Articles

Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.

Pfeffer F, Nauck M, Benz S, Gwodzinski A, Zink R, Busing M Diabetologia. 1996; 39(4):462-8.

PMID: 8777996 DOI: 10.1007/BF00400678.


The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs.

Radziuk J, Barron P, Najm H, Davies J J Clin Invest. 1993; 92(4):1713-21.

PMID: 8104957 PMC: 288331. DOI: 10.1172/JCI116758.

References
1.
Ferrannini E, Cobelli C . The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev. 1987; 3(2):365-97. DOI: 10.1002/dmr.5610030202. View

2.
Reaven G, Olefsky J, Farquhar J . Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes?. Lancet. 1972; 1(7763):1247-9. DOI: 10.1016/s0140-6736(72)90977-4. View

3.
Osei K, Henry M, ODorisio T, Tesi R, Sommer B, Ferguson R . Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes. 1990; 39(10):1235-42. DOI: 10.2337/diab.39.10.1235. View

4.
Henriksen J, Tronier B, Bulow J . Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism. 1987; 36(5):463-8. DOI: 10.1016/0026-0495(87)90044-8. View

5.
Robertson R, Franklin G, Nelson L . Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin. Diabetes. 1989; 38(1):58-64. DOI: 10.2337/diab.38.1.58. View